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ABSTRACT Human DJ-1 is a highly conserved and yet functionally enigmatic protein
associated with a heritable form of Parkinson’s disease. It has been suggested to be
a redox-dependent regulatory scaffold, binding to proteins to modulate their func-
tion. Here we present the X-ray crystal structure of the Toxoplasma orthologue Toxo-
plasma gondii DJ-1 (TgDJ-1) at 2.1-Å resolution and show that it directly associates
with calcium-dependent protein kinase 1 (CDPK1). The TgDJ-1 structure identifies an
orthologously conserved arginine dyad that acts as a phospho-gatekeeper motif to
control complex formation. We determined that the binding of TgDJ-1 to CDPK1 is
sensitive to oxidation and calcium, and that this interaction potentiates CDPK1 ki-
nase activity. Finally, we show that genetic deletion of TgDJ-1 results in upregulation
of CDPK1 expression and that disruption of the CDPK1/TgDJ-1 complex in vivo prevents
normal exocytosis of parasite virulence-associated organelles called micronemes. Overall,
our data suggest that TgDJ-1 functions as a noncanonical kinase-regulatory scaffold that
integrates multiple intracellular signals to tune microneme exocytosis in T. gondii.
IMPORTANCE Apicomplexan parasites such as Toxoplasma and Plasmodium are obli-
gate intracellular parasites that require the protective environment of a host cell in
order to replicate and survive within a host organism. These parasites secrete effec-
tor proteins from specialized apical organelles to select and invade a chosen host
cell. The secretion of these organelles is a tightly regulated process coordinated by
endogenous small molecules and calcium-dependent protein kinases. We previously
identified the Toxoplasma orthologue of the highly conserved protein DJ-1 as a reg-
ulator of microneme secretion, but the molecular basis for this was not known. We
have now identified the molecular mechanism for how TgDJ-1 regulates microneme
secretion. TgDJ-1 interacts with the kinase responsible for the secretion of these or-
ganelles (calcium-dependent kinase 1) and synergizes with calcium to potentiate ki-
nase activity. This interaction is direct, phosphodependent, and necessary for the
normal secretion of these important organelles.
Human DJ-1 (also known as PARK7) is a highly conserved, yet enigmatic proteinmutated in some familial forms of Parkinson’s disease. The structure of the human
DJ-1 protein confirms that it has a papain-like protease fold (1), yet there is no clear
agreement on whether it functions as bona fide protease. Specifically, the homolog
from the human parasite pathogen Toxoplasma gondii lacks the key histidine base of
the catalytic triad in the papain fold, suggesting that it has functions other than
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proteolysis. Although there have been reports of DJ-1 functioning as a protease (2, 3),
glyoxylase (4), transcriptional coactivator (5), and antioxidant (6), some of the most
compelling data suggest that DJ-1 functions as a redox-dependent chaperone (7) that
interprets intracellular reactive oxygen species (ROS) signals through a hyperreactive
and oxidation-sensitive cysteine located in the so-called nucleophilic elbow (8). A
similarly broad function was recently proposed for the Plasmodium falciparum ortho-
logue (9), where it was shown to contribute to parasite virulence. It has also been
proposed that, perhaps similar to the 14-3-3 proteins (10), the DJ-1 superfamily has a
variety of functions mediated through interactions with client proteins or substrates
(11). Although present in all domains of life (12), the molecular basis for interactions
with client proteins and how it regulates the processes they modulate remain largely
unknown.
Intracellular pathogens are dependent upon their chosen host cell niche for survival.
Apicomplexan parasites such as Plasmodium spp. and Toxoplasma gondii utilize a
complex of apical organelles consisting of dense granules, rhoptries, and micronemes,
which they deploy for release (egress), attachment, and invasion of host cells, and the
establishment of the parasitophorous vacuole where the parasite resides inside the
host (13). The contents of these organelles include key molecules for interacting with
the host cell and, correspondingly, their secretion is tightly regulated (14). Microneme
secretion is perhaps the best-understood, with calcium triggering a cascade of events
that result in the activation of calcium-dependent protein kinase 1 (CDPK1) and
microneme secretion (15). Prior to egress, micronemes are thought to release compo-
nents that enable the parasite to escape from the parasitophorous vacuole (16). Once
extracellular, continued release of microneme proteins allows tachyzoites to attach to
cells, to move, and to eventually invade a chosen host cell. Secretion is a calcium-driven
event, which can be artificially stimulated using calcium ionophores or short-chain
alcohols that trigger calcium release from internal stores (17).
In our previous work we identified a small molecule, WRR-086, that inhibited host
cell invasion by T. gondii tachyzoites (18). WRR-086 is a peptide alpha-beta unsaturated
ketone that targets the Toxoplasma orthologue of DJ-1. The binding of WRR-086 to a
specific cysteine residue on T. gondii (TgDJ-1) inhibited microneme secretion and
positioned TgDJ-1 in the same molecular pathway as calcium. Importantly, WRR-086
inhibition of microneme secretion could not be rescued using calcium agonists, dem-
onstrating that, although the presence of calcium is necessary for microneme secretion,
it is not sufficient. Despite the suggestion that TgDJ-1 was a novel regulator of
microneme secretion, the molecular function of TgDJ-1 remained unclear.
Here, we combine structural biology, biochemistry, and cell biology to define a
molecular pathway by which TgDJ-1 regulates microneme secretion. In solving the
X-ray crystal structure of TgDJ-1, we identified a highly conserved arginine dyad that we
confirm as being responsible for a phosphorylation-dependent interaction between
TgDJ-1 and the calcium-dependent protein kinase CDPK1. Surprisingly, and despite its
conservation, this arginine dyad has not been mechanistically dissected in other DJ-1
orthologues. We find that TgDJ-1 synergizes with calcium to potentiate CDPK1 kinase
activity and, furthermore, that the interaction is dependent on calcium levels and
the oxidation state of the environment. To confirm the functional significance of the
TgDJ-1/CDPK1 complex, we engineer WRR-086-insensitive dj-1 alleles and introduce
them into wild-type (WT) parasites. These engineered alleles rescue drug-induced
inhibition of microneme secretion and support a role for the complex in the regulation
of this process. Together, these data suggest that through ROS, calcium, and phos-
phorylation-specific interactions with CDPK1, TgDJ-1 controls exocytosis of key organ-
elles required for pathogenesis.
RESULTS
Structure of TgDJ-1. We previously discovered that TgDJ-1 functions within the
pathway underlying the exocytosis of specialized virulence-associated organelles called
micronemes (18), but the molecular mechanism by which it asserted control over this
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event remained unclear. To get a better sense of structural features important for
TgDJ-1 function, we solved the crystal structure of TgDJ-1 to 2.1 Å (Fig. 1A and Table S4
in the supplemental material). As with other orthologues, TgDJ-1 is a constitutive
homodimer. The target of WRR-086, Cys127, sits next to the nucleophilic pocket that
contains Cys104 (Fig. 1A). As reported for most DJ-1 structures, the reactive Cys104 was
found exclusively in the oxidized sulfinic acid state. The function of DJ-1 as a redox
sensor has been linked to this highly conserved and reactive cysteine at position 106
in humans (12). To independently assess the reactivity of Cys104 in TgDJ-1, we applied
a recently described method that uses cysteine sensitivity to iodoacetamide alkylation
(at two concentrations, high and low) to profile the reactivity of cysteines (19). Using
this approach, the more reactive a cysteine residue is, the closer its ratio score (high
concentration/low concentration) is to 1. We found that TgDJ-1 Cys104 had a cysteine
reactivity ratio score of 2.03 (standard deviation [SD] 0.03), compared with the nearby
reactive cysteine, cysteine 127, that is the target of WRR-086, which had a score of 3.44
(SD  0.21). These data indicate that TgDJ-1 Cys104 is highly reactive, potentially
FIG 1 The structure of TgDJ-1 reveals a conserved arginine dyad that coordinates a direct phosphospecific interaction with CDPK1.
(A) Surface representation of the TgDJ-1 structure, with the two monomers represented in gray and green. The target of WRR-086
modification, Cys127, is highlighted in yellow, and the oxidized Cys104 in the nucleophilic pocket is shown in stick representation. (B
and C) The Arg27/Arg47 dyad coordinates a water molecule with the oxidized Cys104 (B), which is replaced by a PO43 in the structure
of reduced HsDJ-1 (PDB accession no. 3BWE) (C). The structure of HsDJ-1 was overlaid with TgDJ-1, and a portion is shown, with the
residues equivalent to Arg27/Arg47 shown in light blue. For clarity, TgDJ-1 Cys104 is not shown in panel C. (D) Coomassie and Western
blot analysis of pulldown of TgDJ-1 by GST-CDPK1 or GST alone. (E) Coomassie and Western blot analysis of pulldown of TgDJ-1 using
either GST-CDPK1 (CDPK1) or GST-CDPK1 coexpressed with lambda phosphatase (CDPK1  L/phos.). Arrowheads indicate size shifts
for the two purified GST-tagged CDPK1 species. (F) Coomassie and Western blot analysis of pulldown of wild-type TgDJ-1 (WT),
TgDJ-1R47A (R47A), or TgDJ-1R27A/R47A (R27A/R47A) using either GST-CDPK1 (CDPK1) or GST-CDPK1 coexpressed with lambda phos-
phatase (CDPK1  L/phos.). IB, immunoblot.
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explaining its hyperoxidized state in the crystal structure. To precisely define the
reactivity of Cys104, we measured its pKa. We monitored the absorption of the thiolate
anion at 240 nm as a function of pH (20, 21) and determined that it has a pKa of 5.0 
0.1 (see Fig. S1 in the supplemental material). This result further confirms the high
reactivity of this residue and suggests that at physiological pH, this cysteine would be
highly sensitive to oxidation and could function as a ROS sensor as suggested in other
systems (8).
Comparing our structure to previously deposited structures of other DJ-1 family
members, we noted that the two structures of human DJ-1 in which Cys106 is reduced
contain a tetragonal anion (sulfate [PDB accession no. 2OR3] [22] or phosphate [PDB
accession no. 3BWE] [23]). This anion is most prominent in structures of reduced DJ-1,
as it would clash with the oxidized cysteine. We noted that the ion is coordinated by
a highly conserved arginine dyad present in the DJ-1 superfamily of proteins (12)
(Fig. 1B and C). An interesting structural feature is that each arginine of the dyad is
contributed by a different individual monomer unit of the DJ-1 dimer. Despite this high
level of conservation, no function for these residues has been reported for any of the
DJ-1 orthologues, including human.
TgDJ-1 interacts with CDPK1 in a phosphodependent manner. DJ-1 has been
suggested to interact with a variety of proteins (8), leading to speculation that it
functions as a scaffold or chaperone. One of the first proteins shown to directly interact
with human DJ-1 was named DJ-1 binding protein (DJBP) (24), later renamed EF-hand
calcium-binding domain-containing protein 6. That HsDJ-1 can bind to a calcium-
responsive protein is particularly interesting as TgDJ-1 plays a role in the calcium-
triggered process of microneme secretion. CDPK1 is essential for microneme secretion
(15) and has an autoinhibitory C-terminal calmodulin-like domain containing four
tandem EF-hand domains (25) that undergo a dramatic conformational rearrangement
upon calcium binding to activate the kinase. This led us to hypothesize that TgDJ-1
could regulate microneme secretion directly through an interaction with CDPK1. To test
this, we performed in vitro association studies using recombinant glutathione S-transferase
(GST)-tagged CDPK1 and recombinant TgDJ-1 (rTgDJ-1). These studies confirmed that
GST-CDPK1, and not GST alone, was able to precipitate rTgDJ-1, demonstrating that
these two proteins can interact directly and that the complex requires no additional
factors for formation (Fig. 1D).
Many kinases are regulated by autophosphorylation (26). CDPK1 contains at least
three major phosphosites (serine 25, 61, and 349), identified in a recent phosphopro-
teomic study (27). In light of this and the insights gleaned from the crystal structure, we
investigated whether phosphorylation of CDPK1 was critical for its interaction with
TgDJ-1. Coexpression of CDPK1 with lambda phosphatase in Escherichia coli produces
homogenously dephosphorylated recombinant kinase for crystallographic studies (25).
The previous successful crystallization of CDPK1 coexpressed with lambda phosphatase
reassured us that the protein would likely be correctly folded but lack phosphorylation
modifications. Using this protocol, we expressed and purified dephosphorylated GST-
tagged CDPK1. Conversion to the dephosphorylated state was confirmed by a modest
SDS-PAGE shift of the GST-CDPK1 expression product (Fig. 1E). We then tested the
ability of either phosphorylated or dephosphorylated CDPK1 to precipitate rTgDJ-1.
Remarkably, the interaction displayed absolute dependence upon the phosphostate of
the kinase, with TgDJ-1 associating only with a phosphorylated form of CDPK1 (Fig. 1E).
The TgDJ-1 crystal structure led us to consider a possible function for the highly
conserved arginine dyad as a phosphate-coordinating motif located on the edge of the
nucleophilic trough. As both arginine residues are expected to be required for correct
coordination of the tetragonal anion, we predicted that mutation of a single arginine
of the dyad would prevent correct coordination of the charged phosphate group and
abrogate binding. To directly test this, we mutated the two arginine residues at
positions 27 and 47 to alanine. We expressed and purified a single mutant, TgDJ-1R47A,
and the double mutant, TgDJ-1R27A/R47A, and then tested whether these residues were
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involved in the interaction. Our attempts to generate the single TgDJ-1R27A mutant
were unsuccessful. As we had previously observed, the TgDJ-1 wild-type strain (TgDJ-
1WT) interacted only with phosphorylated CDPK1 (Fig. 1F). As expected, when a single
arginine of the dyad was mutated to an alanine in TgDJ-1R47A, CDPK1 was unable to
interact regardless of its phosphorylation state (Fig. 1F). In contrast, the double mutant
(TgDJ-1R27A/R47A) was able to bind to CDPK1 regardless of its phosphorylation state
(Fig. 1F). These data are consistent with the TgDJ-1 arginine dyad functioning as a
phosphorylation recognition motif or gatekeeper, facilitating recognition of phosphor-
ylated CDPK1 by TgDJ-1.
The association of TgDJ-1 with CDPK1 is context dependent. In light of the
published role for DJ-1 in sensing intracellular reactive oxygen species (28) and for
CDPK1 as a calcium sensor (25), we sought to test if these naturally occurring signaling
molecules could influence the interaction of the two proteins. For this purpose, we used
a more authentic “cell extract” system in which we manipulated the calcium and redox
conditions. We prepared soluble cell extracts from naturally egressed CDPK1-hemag-
glutinin (CDPK1-HA) tachyzoites and adjusted the extracts to make them either calcium
rich (calcium) or calcium depleted (EGTA), as well as reducing (dithiothreitol
[DTT]) or oxidizing (H2O2). We used H2O2 as the oxidizing agent as it is broadly
regarded as the most relevant candidate for the transduction of ROS signals (29). After
addition of recombinant TgDJ-1 (rTgDJ-1), we immunoprecipitated (IP) CDPK1-HA and
assessed the ability of the kinase to coprecipitate rTgDJ-1. Interestingly, the interaction
between rTgDJ-1 and CDPK1-HA was both calcium and H2O2 dependent (Fig. 2A), with
rTgDJ-1 predominantly interacting with CDPK1 in reducing conditions and in the
absence of calcium.
We next sought to determine if specific signals could trigger dissociation of the
TgDJ-1/CDPK1 complex. We isolated the complex from soluble cell extracts using
FIG 2 The association and stability of the TgDJ-1/CDPK1 complex are sensitive to secondary messengers.
(A) Western blot analysis of the ability of HA-tagged CDPK1 to coprecipitate FLAG-tagged TgDJ-1 under
low-calcium (5 mM EGTA) (calcium) or high-calcium (5 mM CaCl2) (calcium) conditions and
reductive (R) or oxidative (Ox) conditions. IP, immunoprecipitation. IB, immunoblot. (B) Western blot
analysis of the stability of isolated TgDJ-1/CDPK1 complex in the presence of 5 mM calcium ( calcium),
hydrogen peroxide (H2O2), or both.
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conditions that favored its assembly (reducing and calcium depleted) and then incu-
bated with calcium or H2O2. Interestingly, the addition of either calcium or H2O2 alone
was not sufficient to trigger dissociation of the complex (Fig. 2B). However, in the
presence of both calcium and ROS, the complex dissociated (Fig. 2B). These data
suggest that the TgDJ-1/CDPK1 complex could function as a sensor for these two
secondary messengers.
TgDJ-1 potentiates CDPK1 activity. To determine if DJ-1 binding had any direct
effect on CDPK1 function, we performed an in vitro kinase assay, measuring residual
ATP levels present in a given reaction following phosphorylation of a peptide substrate
as an endpoint read (low signal high kinase activity). We optimized the concentration
of CDPK1 based on its 50% effective concentration (EC50) of ~15 nM, hypothesizing that
this concentration of kinase would provide sufficient dynamic range to distinguish
between inhibition and activation in subsequent experiments (Fig. 3A). CDPK1 has
been structurally confirmed to exist in two distinct conformers (25): apo (calcium-
free, inactive) and calcium-bound (active). Intracellular concentrations of calcium in
tachyzoites have been estimated to be between 50 and 100 nM (30); however, we
observed kinase activity at relatively high concentrations of between 5 and 50 M
calcium (Fig. 3B). On the basis of these data, we induced binding of TgDJ-1 under low
(50 nM)-calcium conditions, followed by the addition of ATP and peptide substrate and
a high calcium concentration (500 M) to stimulate full activation of the kinase. To test
if TgDJ-1 affected the activity of the kinase, we titrated wild-type TgDJ-1 against CDPK1
and discovered that TgDJ-1 increased the activity of CDPK1 in a dose-dependent
manner (Fig. 3C). We did not observe this effect in the absence of the peptide substrate,
indicating that the effect was most likely due to increased phosphorylation of the
peptide rather than to increased CDPK1 autophosphorylation or phosphorylation of
TgDJ-1.
We then tested whether the presence of TgDJ-1 was sufficient to activate CDPK1,
whether activation still required calcium, and if any effect observed was additive or
synergistic. We performed an assay where different concentrations of TgDJ-1 (low,
0.26 M; high, 2.6 M) were added to CDPK1, followed by the addition of the peptide
substrate, ATP, and 500 M EDTA or a low (50 nM) or high (500 M) concentration of
calcium. Neither the EDTA-treated samples nor the low-calcium-treated samples exhib-
ited any appreciable activity, and this was unaffected by the presence of TgDJ-1
(Fig. 3D, EDTA and 50 nM sections of scatter plots). We once again observed that high
concentrations of calcium activated the kinase and that TgDJ-1 stimulated this activity
in a dose-dependent manner (Fig. 3D; 500 M section of scatter plot). Thus, the calcium
and TgDJ-1 effects on CDPK1 activity appear to be synergistic in nature. Assays
performed with TgDJ-1 in the absence of CDPK1 produced no signal, confirming that
the observed signals for the TgDJ-1-plus-CDPK1 (TgDJ-1CDPK1) samples were not
due to contaminants in the TgDJ-1 recombinant protein preparations (Fig. 3D).
We hypothesized that the activation observed with different concentrations of
calcium was a reflection of CDPK1 transitioning from the apo state to the fully active
conformer (Fig. 3B) (25). To investigate how these different calcium-bound CDPK1
conformers responded to TgDJ-1 potentiation, TgDJ-1 was allowed to associate with
CDPK1 in the presence of a titration of calcium. We observed that in high concentra-
tions of calcium, the potentiation effect of TgDJ-1 was blocked, with kinase activity
returning to the level seen with kinase alone (Fig. 3E).
Combining our insights from the crystal structure and the precipitation data, we
hypothesized that if the association of TgDJ-1 with CDPK1 were necessary to potentiate
kinase activity, TgDJ-1 mutations predicted or directly shown to affect the interaction
could alter its ability to influence kinase activity. We assayed a panel of TgDJ-1 mutants
for their ability to potentiate CDPK1 activity. These included the arginine dyad mutants
(R47A, R27A/R47A) and an additional mutant where the reactive cysteine C104 was
mutated to an alanine (C104A) that we predicted could participate in the interaction on
the basis of the crystal structure. Consistent with our precipitation data, the R47A
Child et al. ®
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FIG 3 TgDJ-1 potentiates CDPK1 kinase activity, with the effect dependent upon, and synergistic with, calcium. (A) Kinase activity
assay to optimize CDPK1 concentration. Scatter plot of data points from a kinase assay optimizing the concentration of CDPK1 kinase
required to generate robust signal for 10 M syntide and 10 M ATP. (B) Kinase activity assay to optimize calcium concentration for
CDPK1 activation. Scatter plot of data points from a kinase assay testing the concentration of calcium required to fully activate CDPK1.
(C) Kinase activity assay testing the effect of TgDJ-1 upon CDPK1 activity. Scatter plot of data points from a kinase assay where TgDJ-1
was titrated against CDPK1, either in the presence (CDPK1DJ-1) or absence of the peptide substrate (no syntide). (D) Kinase assay
testing the effect of calcium on pre-complexed CDPK1DJ-1. Scatter plot of kinase assay data points where CDPK1 alone (CDPK1 only),
TgDJ-1 alone (DJ-1 only), or TgDJ-1CDPK1 (DJ-1CDPK1) was incubated with EDTA, 50 nM, or 500 M calcium. Two concentrations
of TgDJ-1 were used: 0.26 M (low DJ-1) or 2.6 M (high DJ-1). Significance was calculated for a two-way ANOVA statistical analysis
(with Dunnett’s multiple comparison test) comparing each group of means (EDTA, 50 nM or 500 M calcium) with the CDPK1 only
control within the group. ns, not significant; ****, P  0.0001. (E) Kinase assay testing the effect of incubating CDPK1 with TgDJ-1 in
the presence of a titration of calcium. Histogram of kinase assay data points for CDPK1 only, or TgDJ-1CDPK1 pre-incubated with
5, 50, 500, or 5,000 M calcium. Data presented are the means of three replicates, with error bars indicating  SD. Significance was
calculated for an ordinary one-way ANOVA statistical analysis (with Dunnett’s multiple comparison test) comparing each mean with
the CDPK1 only control. ns, not significant; ****, P  0.0001. (F) Kinase assay testing the capacity of different TgDJ-1 mutants to
potentiate CDPK1 activity. Histogram of kinase assay data points for CDPK1 alone (CDPK1 only), or CDPK1 incubated with 10 M
wild-type, C104A, R47A, or R27A/R47A mutant TgDJ-1 protein. Data presented are the means of three replicates, with error bars
indicating  SD. Significance was calculated for an ordinary one-way ANOVA statistical analysis (with Dunnett’s multiple comparison
test) comparing each mean with wild-type TgDJ-1 (WT). ns, not significant; ****, P  0.0001. The panel beneath the histogram is a
Coomassie stained gel indicating equal input of the different TgDJ-1 mutant proteins in the kinase assay reactions. For panels A, B,
C, and D, data presented are the means of three replicates, with error bars indicating  SD. RLU, relative light units.
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mutant that failed to associate with CDPK1 (Fig. 1F) was defective in its ability to
potentiate CDPK1 activity (Fig. 3F). The double-arginine mutant (R27A/R47A) that
constitutively associated with CDPK1 irrespective of its phosphorylation state (Fig. 1F)
potentiated kinase activity to a degree similar to that seen with wild-type TgDJ-1
(Fig. 3F). Interestingly, the C104A mutant displayed a similar loss in its ability to
potentiate kinase activity, indicating that this critical and highly conserved residue may
also contribute to the interaction.
TgDJ-1 regulates microneme secretion. Given the structural and functional data
suggesting a potential biological role for the DJ-1/CDPK1 complex, we moved to an
intact cell system to validate the relevance of the complex. We began by deleting the
native dj-1 (TGGT1_214290) locus using double homologous recombination in the
RHΔku80 parasite line to replace the gene with the HXGPRT drug selection cassette
(Fig. 4A). We confirmed successful deletion of the dj-1 locus by diagnostic PCR analysis
(Fig. 4B). To better assess the knockout parasites (the ΔTgdj-1 mutants), we raised a
murine polyclonal antibody against E. coli-expressed recombinant TgDJ-1 (18). When
used to probe Western blots of whole tachyzoite lysates, the antibody recognized a
single species of ~22 kDa (Fig. S2A), consistent with its predicted size of 19.5 kDa, and
biochemical fractionation showed that TgDJ-1 partitioned exclusively to the cytosolic
compartment (Fig. S2B). This result was supported by its localization in immunofluo-
rescence assays (Fig. S2C). We isolated clonal populations of knockout parasites by
limiting dilution, and Western blot analysis confirmed the absence of the TgDJ-1
protein (Fig. 4C). Plaque assays indicated that ΔTgdj-1 parasites grew normally in terms
of both plaque number and size (Fig. 4D), suggesting that, in this genetic background
and under the conditions used for cell culture, TgDJ-1 is nonessential or can be readily
compensated for. Likewise, the motility of ΔTgdj-1 parasites in two dimensions (2D) was
indistinguishable from the motility of the wild type (Fig. 4E).
The original identification of TgDJ-1 as the target of the small molecule WRR-086
suggested that it was involved in the regulation of microneme secretion (18). With this
in mind, we investigated if microneme secretion was altered in ΔTgdj-1 parasites.
Microneme secretion can be monitored over time by detection of microneme protein
2 (MIC2) in culture supernatant following its release by organelle exocytosis. Basal
microneme secretion in two knockout clones selected from two independent transfec-
tions (clones C10 and F6) was increased compared to that seen with the RHΔku80
parent (WT) line (Fig. 4F and G and 5A and B). As both of the ΔTgdj-1 clones exhibited
the same phenotype, we continued our studies focusing on clone F6. Consistent with
atypical microneme secretion, ΔTgdj-1 parasites were moderately less proficient at
invading host cells during a time-restricted attachment/invasion assay (Fig. 4H). As
microneme secretion provided the clearest readout for the phenotype resulting from
the loss of TgDJ-1, we focused on this assay for the remainder of the study. To
determine if the absence of TgDJ-1 was the only factor responsible for the microneme
secretion defect, we performed a genetic rescue through complementation performed
with an N-terminally FLAG-tagged TgDJ-1 protein expressed under the control of the
GRA1 promoter and targeted to the UPRT locus of ΔTgdj-1 parasites (ΔTgdj-1WTcomp)
(Fig. S3A). Expression of FLAG-tagged DJ-1 was confirmed by Western blotting
(Fig. S3B), and a single clone (D3) selected for further characterization. Surprisingly,
ΔTgdj-1WTcomp parasites had reduced levels of basal microneme secretion compared to
both wild-type and knockout parasites (Fig. 5A and B). As there are two distinct modes
of microneme secretion, we next tested whether induced secretion was similarly
affected by complementing the transgene. Ethanol-stimulated microneme secretion in
wild-type parasites was induced to a higher level in ΔTgdj-1 parasites than in the
parental strain (Fig. 5C and D). Furthermore, the rescue of TgDJ-1 expression in the
complemented ΔTgdj-1WTcomp cell line decreased the response of secretion to ethanol
stimulation, reducing it to levels below those seen with WT parasites (Fig. 5C and D). In
an attempt to better understand these results, we examined the expression levels of
TgDJ-1 and found that it was dramatically overexpressed in the ΔTgdj-1WTcomp parasites
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FIG 4 Phenotypic characterization of ΔTgdj-1 parasites. (A) Strategy to replace the native dj-1 locus with the
drug-selectable HXGPRT cassette and generate the ΔTgdj-1 parasite line. (B) PCR confirmation of loss of the dj-1
locus in two individual clones (C10 and F6) isolated from two independent transfections (Tf1 and Tf2). (C) Western
blot confirmation of the loss of TgDJ-1 protein expression in the same ΔTgDJ-1 parasite clones. SAG1, loading
control. (D) Plaque assays comparing growth of wild-type (WT) and TgDJ-1 knockout (ΔTgDJ-1) parasites. (E) Gliding
motility assays comparing the 2D motility of wild-type (WT) and TgDJ-1 knockout (ΔTgdj-1) parasites. (F) Mi-
croneme secretion assays comparing the levels of basal secretion of MIC2 over time for the wild-type (WT) strain
and two individual ΔTgDJ-1 clones (C10 and F6) isolated from two independent transfections. GRA7, loading
control. (G) Quantification of the microneme secretion assays. Asterisk indicates the level of significance as
determined by Student’s t test; data represent means  SD for results from n  3 experiments. (H) Attachment/
invasion assay comparing wild-type (WT) and TgDJ-1 knockout (ΔTgdj-1) parasites. The histogram presents the
quantification of raw parasite numbers for attachment/invasion assays for the wild-type (WT) strain versus ΔTgdj-1
clone F6. Asterisk indicates the level of significance as determined by Student’s t test; data represent means  SD
for results from n  3 experiments.
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FIG 5 TgDJ-1 regulates microneme secretion. (A) Western blots of microneme secretion assays comparing
levels of basal secretion of MIC2 over time for wild-type (WT), ΔTgdj-1 clone F6, and ΔTgdj-1 parasites
complemented with wild-type Tgdj-1 (ΔTgdj-1WTcomp). GRA7, loading control. (B) Quantification of basal
microneme secretion assays; data represent means  SD for results from n  3 experiments. Significance was
calculated for a two-way statistical ANOVA for comparison of the different strains (WT, ΔTgdj-1, and ΔTgdj-
1WTcomp) (****, P 0.0001) and the different time points (15, 30, and 60 min) (****, P 0.0001). Post hoc pairwise
comparisons of the different strains at each time point were performed using Tukey’s multiple-comparison test
and the data presented in Table S1. (C) Western blots of microneme secretion assays comparing ethanol-
induced secretion of MIC2 with different concentrations of ethanol for the wild-type strain (WT), the TgDJ-1
knockout strain (ΔTgDJ-1), and the TgDJ-1 knockout strain complemented with wild-type TgDJ-1 (ΔTgDJ-
1WTcomp). GRA7, loading control. (D) Quantification of induced microneme secretion assays; data represent
means  SD for results from n  3 experiments. Significance was calculated for a two-way statistical ANOVA
for comparison of the different strains (WT, ΔTgdj-1, and ΔTgdj-1WTcomp) (****, P  0.0001) and the different
proportions of EtOH (0%, 0.1%, and 1%) (****, P 0.0001). Post hoc pairwise comparisons of the different strains
at each ethanol concentration were performed using Tukey’s multiple-comparison test and the data presented
in Table S2. (E) Western blot comparing expression levels of CDPK1 in wild-type (WT), ΔTgdj-1, and ΔTgdj-
1WTcomp parasites. SAG1, loading control. (F) Quantification of CDPK1 expression levels. Data represent
means  SD for results from n  3 experiments. Significance was calculated for an ordinary one-way
statistical ANOVA to assess the difference between the means (***, P  0.001). Results of a post hoc Tukey’s
multiple-comparison test for pairwise comparisons of wild-type (WT), Tgdj-1, and ΔTgdj-1WTcomp parasites
are presented. ns, not significant. **, P  0.01. ***, P  0.001.
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compared to native TgDJ-1 expression levels (Fig. S3C). This was likely due to the use
of the GRA1 promoter to drive its expression. Despite the observed differences in
microneme secretion, ΔTgdj-1WTcomp parasites grew normally in terms of plaque num-
ber and size (Fig. S3D). Combined, these data confirm that TgDJ-1 plays a regulatory
role in both basal and induced microneme secretion.
To confirm that the TgDJ-1/CDPK1 interaction occurred in cells, we performed
coimmunoprecipitations (co-IPs) using parasite strains expressing epitope-tagged ver-
sions of TgDJ-1 (FLAG-TgDJ-1 in ΔTgdj-1WTcomp parasites) to pull down endogenous
CDPK1 or parasite strains expressing hemagglutinin-tagged CDPK1 (CDPK1-HA) (31) to
pull down endogenous TgDJ-1. Though suggestive of an interaction, the results from
these coimmunoprecipitations were inconsistent, leading us to speculate that the
interaction may be of low affinity or that the context dependence of the interaction was
too sensitive or transient to capture in these coimmunoprecipitations.
On the basis of the known role for CDPK1 as an essential regulator of microneme
secretion (15), our data showing that TgDJ-1 interacts with CDPK1 (Fig. 1D and E and
2), and the observed microneme secretion phenotype in the ΔTgdj-1 and ΔTgdj-
1WTcomp parasites (Fig. 4F and G and 5A and B and C and D), we examined the levels
of CDPK1 expression in these different parasite lines. Intriguingly, CDPK1 protein levels
showed a striking inverse relationship to the amount of TgDJ-1 present in the cell; in
the absence of TgDJ-1, CDPK1 was more abundant at the protein level, with the
amount of CDPK1 being ~3 times greater in ΔTgdj-1 parasites than in the wild type
(Fig. 5E and F). To determine if this was a general mechanism by which parasites coped
with the loss of TgDJ-1, we assessed the level of CDPK1 expression in a second ΔTgdj-1
clone isolated from an independent transfection and found that it was similarly
increased (Fig. S4). These data suggested that compensating for the loss of TgDJ-1 by
increasing the amount of CDPK1 present in the cell is a potential mechanism of
adjustment within the pathway. In agreement with this, CDPK1 levels in ΔTgdj-1WTcomp
parasites were lower than in the knockout strain (Fig. 5E and F).
Drug-insensitive dj-1 alleles enable dissection of mutant function in cells. We
sought to test if mutations that affected the DJ-1/CDPK1 complex and the ability of
TgDJ-1 to potentiate CDPK1 activity also influenced its ability to regulate microneme
exocytosis. Initial attempts to introduce mutant dj-1 alleles into parasites proved
unsuccessful, suggesting that the arginine dyad mutations were not tolerated when
expressed in ΔTgdj-1 parasites, eliminating the possibility of examining the function of
these mutations by direct gene replacement strategies. To overcome this technical
problem, we attempted to generate dj-1 alleles N-terminally tagged with an FKBP-
derived destabilization domain (32). However, the incorporation of this domain resulted
in a fusion protein that was not stably expressed. In our previous work, we demon-
strated that the small molecule WRR-086 targets a nonconserved cysteine at position
127 (Cys127) (18). Mutation of this cysteine in the native dj-1 locus protected parasites
from the effect of the drug. This led us to consider an alternative strategy using
the C127A mutation to engineer drug-insensitive dj-1 alleles that could be expressed in
the background of wild-type TgDJ-1, making the parasitesmerodiploid for the gene. The
wild-type allele could then be selectively targeted with WRR-086, allowing any pheno-
type associated with other mutations carried on the C127A background to be revealed
through complementation (Fig. 6A). We anticipated that these mutant proteins would
be phenotypically dominant in the presence of drug, allowing us to test the functional
contribution of the mutations found to affect the ability of TgDJ-1 to potentiate CDPK1
activity in vitro with kinase function in cells. We expected that any mutation that
affected the nature of the interaction would be unable to functionally complement the
loss of the wild-type protein.
We transfected tachyzoites with constructs to overexpress a FLAG-tagged TgDJ-
1C127A mutant allele in the background of the endogenous TgDJ-1 through use of the
GRA1 promoter to drive the transgene. Using this approach, we generated the TgDJ-
1/TgDJ-1C127A merodiploid line (Fig. 6A), as well as lines that expressed the C104A,
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FIG 6 Engineered drug-insensitive TgDJ-1 alleles confirm the functional contribution of the TgDJ-1/CDPK1
complex to microneme secretion. (A) Schematic of the strategy to engineer and introduce drug-insensitive alleles
to generate merodiploid parasite strains. (B) Western blot analysis using both anti-CDPK1 and anti-FLAG antibodies
for expression of CDPK1 and FLAG-tagged TgDJ-1 in isogenic parasite strains expressing either TgDJ-1C127A
(C127A), TgDJ-1C127A/C104A (C104A), TgDJ-1C127A/R47A (R47A), or TgDJ-1C127A/R27A/R47A (R27A/R47A). This
nomenclature for the merodiploid parasites is used throughout. (C) Indirect immunofluorescence assays examining
the localization of intracellular TgDJ-1 merodiploid parasites. Gliding-associated protein 45 (GAP45) is used as a
marker for the inner-membrane complex/plasma membrane; DAPI, nuclear stain. Scale bar  5 M. (D) Plaque
assays comparing growth of wild-type and TgDJ-1 merodiploid parasites. (E) Quantification of Western blot analysis
of induced microneme secretion assays performed in the presence of a titration of WRR-086. Data represent
means  SD for n  3 experiments. Significance was calculated for a two-way ANOVA statistical analysis
comparing wild-type and all merodiploid strains. Significance for comparison of the different strain group
means  **** (P  0.0001); and the different WRR-086 concentrations (0, 1, 5, 10 M)  **** (P  0.0001).
Post-hoc pairwise comparison of the different strains for each WRR-086 concentration was performed using
Tukey’s multiple comparison test and the data presented in Table S3.
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R47A, and R27A/R47A mutations maintained in the background of the drug-insensitive
C127A allele, referred to as TgDJ-1/TgDJ-1C127A/C104A, TgDJ-1/TgDJ-1C127A/R47A, and
TgDJ-1/TgDJ-1C127A/R27A/R47A, respectively. We isolated isogenic populations of para-
sites expressing FLAG-tagged TgDJ-1 mutant alleles and confirmed equivalent relative
expression levels of the mutant proteins by Western blotting (Fig. 6B). Unlike the results
seen with the ΔTgDJ-1 parasites, we found that the levels of CDPK1 were unaffected by
the introduction of these mutant proteins (Fig. 6B). Indirect immunofluorescence assay
(IFA) results confirmed a diffuse cytosolic distribution for the overexpressed mutant
proteins that matched that observed for native TgDJ-1 (Fig. 6C and S2C). All merodip-
loid TgDJ-1 parasite lines grew normally, generating plaques that were equal in number
and size to wild-type plaques (Fig. 6D). Together, these data confirmed that the mutant
proteins were expressed and localized appropriately to potentially complement the
native gene product. We next tested the ability of the mutant alleles to rescue
inhibition of microneme secretion by WRR-086, and, importantly, microneme secretion
was similar to wild-type secretion levels in the absence of drug for all merodiploid lines
(Fig. S5). As anticipated, TgDJ-1/TgDJ-1C127A parasites were resistant to the effect of
WRR-086, exhibiting relatively normal levels of microneme secretion in the presence of
the drug (Fig. 6E). It should be noted that, although TgDJ-1/TgDJ-1C127A parasites were
resistant to WRR-086, the level of rescue achieved was not complete, suggesting that
the overexpression of the C127A allele could not fully complement the loss of function
of the native protein. Parasites expressing the TgDJ-1C127A/C104A allele were partially
resistant to the effects of WRR-086, but the level of phenotypic rescue achieved was
lower than that seen with the TgDJ-1C127A allele (Fig. 6E), supporting the kinase assay
data indicating a likely critical role for this residue in the potentiation of CDPK1 activity
and TgDJ-1 function in microneme secretion. As expected, and in accordance with our
in vitro biochemical data showing that the mutation of one arginine of the dyad
prevented association of TgDJ-1 with the kinase, the TgDJ-1C127A/R47A allele was
incapable of rescuing microneme secretion in the presence of drug (Fig. 6E). Intrigu-
ingly, TgDJ-1/TgDJ-1C127A/R27A/R47A parasites displayed drug sensitivity that was similar
to that seen with parasites expressing the single arginine mutant (TgDJ-1/TgDJ-
1C127A/R47A; Fig. 6E). These data confirm that mutations that disrupt or change the
features of the TgDJ-1/CDPK1 complex also influence the ability of the protein to
regulate microneme exocytosis in vivo.
DISCUSSION
The specific cellular functions of DJ-1 have remained unclear despite its association
with Parkinson’s disease and cancer (8). We initiated this study on the basis of our
previous finding that the T. gondii orthologue of DJ-1 was somehow functionally
involved in the regulation of exocytosis of invasion-associated organelles called mi-
cronemes (18). Here we present a speculative molecular explanation for how TgDJ-1
can control this critical cellular event, through direct interaction with the calcium-
dependent kinase CDPK1 (Fig. 7). The basis for this pathway is an association between
TgDJ-1 and CDPK that is dependent on both redox and environmental calcium levels,
as well on phosphorylation of the kinase. Thus, TgDJ-1 regulates the CDPK1-mediated
signaling necessary for the coordination of microneme secretion.
Our findings raise the following question: how is it that the DJ-1/CDPK1 complex is
stable under conditions that preclude its formation? Mechanistically, we hypothesize
that TgDJ-1 locks CDPK1 in an unsaturated calcium conformer and that reactive oxygen
species can promote a relaxation of the interaction by lowering the dissociation
constant (Kd) of the interaction. In this relaxed state, CDPK1 conformationally responds
to a calcium signal and undergoes a further structural rearrangement with respect to
the calcium-saturated conformer (25). The calcium-mediated effect is therefore robust
and switch-like, with calcium triggering a rearrangement in the conformation of CDPK1
to a form that is no longer recognized by TgDJ-1, i.e., that is not competent to associate
with TgDJ-1 at all. With this in mind, our data would indicate that the calcium signal is
likely to be dominant. Though our data suggest that the oxidation state of TgDJ-1 could
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modulate complex stability, the molecular basis for this is still unclear, and the specific
contribution of the reactive C104 to the association with CDPK1 is being investigated
in more detail. Considering the merodiploid data for the C104A mutant, the critical
comparison is the C127A mutant with the C127A/C104A mutant. These data suggest
that although this mutant is still able to complement the wild-type protein function in
the presence of low concentrations of drug, at the higher concentrations of WRR-086
(those at which we anticipate that the bulk of the interaction is forced to occur via the
C127A allele product), the C104A mutation cannot functionally complement the native
gene product, as expected on the basis of the data presented in Fig. 3F. Although
TgDJ-1 and calcium seem to function synergistically to potentiate CDPK1 activity
(Fig. 3D), the order of their binding to the kinase appears to be critical. Driving CDPK1
toward a calcium-saturated conformation prevents TgDJ-1 association and subsequent
potentiation of kinase activity. However, it should be noted that the ability of high
calcium concentrations to abrogate the activation effect of TgDJ-1 could be the result
of ionic shielding of the electrostatic interactions between the arginine dyad and the
phosphorylation site on CDPK1. These data are consistent with the coprecipitation data
indicating that the complex could not form under calcium-rich conditions (Fig. 2A). We
hypothesize that TgDJ-1 associates with CDPK1 under low-calcium conditions but that
formation of this complex is not sufficient to activate the kinase. Calcium is still required
and then functions synergistically with TgDJ-1 to potentiate CDPK1 activity.
The fact that coincidental detection of a calcium and ROS signal is necessary for
efficient dissociation of the complex is a particularly interesting feature of the interac-
FIG 7 Model molecular pathway for the regulation of microneme secretion by TgDJ-1 and CDPK1. (A) CDPK1 is
thought to autophosphorylate as part of its mechanism of activation. The negatively charged phosphate is
indicated (-P-). (B) Under reducing conditions, TgDJ-1 associates with the phosphorylated, calcium-depleted
conformer of CDPK1 to produce state B, with the negative charge of the phosphate recognized and coordinated
by the conserved arginine dyad on TgDJ-1. These positively charged arginine residues are indicated (). (C) The
addition of calcium produces the final biologically active TgDJ-1/CDPK1 complex, as illustrated, with TgDJ-1
synergizing with calcium to potentiate CDPK1 activity. This potentiated complex is required to maintain normal
microneme secretion. (D) The combination of a calcium and ROS signal (possibly H2O2) triggers dissociation of the
complex, returning CDPK1 to the unbound, lower-activity state, allowing the kinase to recycle to reassociate with
a pool of reduced TgDJ-1 protein. (E) The small-molecule inhibitor WRR-086 binds to TgDJ-1 and potentially
prevents association with CDPK1. This prevents of the formation of the TgDJ-1/kinase complex shown in panel B,
with the net result being that the CDPK1 cannot achieve the TgDJ-1-potentiated activity state, leading to a block
in microneme secretion as previously reported (18).
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tion. Given that formation of the complex seems to be required for maintaining normal
microneme secretion, dissociation of the complex triggered by calcium and H2O2 could
be a negative-feedback mechanism. Coincidental detection of these two signals would
result in the complex dissociating, and CDPK1 could then be recycled back to reasso-
ciate with a reduced pool of TgDJ-1. This could produce an oscillation of CDPK1 activity.
Intriguingly, parasite motility (a process driven by microneme components following
exocytosis) appears to be a pulsed, oscillatory process, with the motility of extracellular
parasites fluctuating in waves (33).
The high concentration of TgDJ-1 required for activation of CDPK1 could be a
reflection of the low Kd of the interaction. Typical “biologically relevant” protein-protein
interactions have a Kd in the low micromolar range, which would be consistent with our
in vitro data for CDPK1 kinase activity. Such a low-affinity and possibly transient
interaction may also explain why we were unable to isolate the complex from cells
expressing native levels of tagged versions of either target. In further agreement with
the presence of a potentially low-affinity complex that is regulated by multiple factors,
our attempts to generate a crystal structure of the DJ-1/CDPK1 complex failed due to
the fact that it does not appear to be stable enough to allow its isolation in sufficient
purity for structural studies. Though we are confident that our data support this model,
the stabilization and capture of the TgDJ-1/CDPK1 complex from within the cellular
environment are top priorities for future studies.
In addition to the role of calcium and H2O2, the formation of the DJ-1/CDPK1 complex
exhibited binary dependence upon the phosphostate of the kinase. The identification of a
conserved arginine dyad as the primary site for recognition of phosphate is particularly
important as it provided us with the ability to alter the interaction of CDPK with DJ-1
by mutation of these residues. Given the similarity between TgDJ-1 and other DJ-1
orthologues, it seems reasonable to speculate that the arginine dyad coordinates the
tetragonal phosphate anion, with each residue contributing to the coordination. There-
fore, the expectation would be that a single arginine would not be able to correctly
coordinate the phosphate, and this is what we observed for the single-point mutant.
However, mutation of both residues of the dyad to alanine should dramatically increase
the overall space where the phosphate binds, and also remove the charges in the
pocket. This could allow binding of CDPK1 regardless of its phosphorylation state, as we
observed in our studies. Furthermore, the TgDJ-1/CDPK1 interaction is observed only
under reducing conditions, with oxidation necessary for dissociation. Our crystal struc-
ture of TgDJ-1 indicates that, when oxidized, Cys104 may electrostatically clash with the
anion coordinated by the Arg dyad, which may function to destabilize the interaction.
Though it is generally highly conserved, we were surprised to note that the arginine
dyad is not conserved in the closely related (but evolutionarily divergent) apicomplexan
parasite, Plasmodium spp. This could mean that the interaction of DJ-1 with the
equivalent kinase in Plasmodium does not occur, and that alternative regulatory
mechanisms may have evolved to tune the activity of the kinase primarily responsible
for coordinating microneme secretion in this parasite.
We initially found it somewhat surprising that, in our biochemical assays, the
double-arginine mutant TgDJ-1 associated with CDPK1 independently of its phosphor-
ylation state and yet failed to complement the loss of WT TgDJ-1 function in cells. Our
results may be explained by the fact that TgDJ-1 is a dimer, with the arginine dyad
consisting of residues contributed by both monomers of the dimer. Thus, by expressing
a mutant monomer in cells that also express the WT TgDJ-1, it is possible that we
generated mixed heterodimers in which one of the two binding sites contains the
drug-sensitive Cys127 that has the WT arginine residues and the other contains the
insensitive C127A mutation carrying the arginine mutations. This would result in a
drug-insensitive complex containing only a single arginine site mutation which, like the
TgDJ-1C127A/R47A protein, would not productively form complexes with CDPK1. How-
ever, it should be noted that the overexpression of the mutant alleles would likely make
this heterodimer scenario rare. Alternatively, the change in the nature of binding of the
double-arginine mutant (i.e., to a non-phospho-dependent mode) could prevent it
TgDJ-1 Regulates CDPK1 ®
January/February 2017 Volume 8 Issue 1 e02189-16 mbio.asm.org 15
from supporting normal microneme secretion because a key part of the regulatory
mechanism that controls which phosphorylated form of CDPK1 binds would be lost.
The conservation of the arginine dyad across diverse DJ-1 orthologues draws
attention to the possibility that these residues have a conserved function in other
organisms, including humans. For example, the human DJ-1 protein has been shown to
interact with a wide variety of proteins such as DJBP (24) and, intriguingly, apoptosis
signal-regulating kinase 1 (34). Given that the interaction of TgDJ-1 with CDPK1 directly
affects kinase activity and the high sequence and structure conservation (35% identity
for Toxplasma gondii versus Homo sapiens; root mean square deviation [RMSD]  1.45),
it would be worthwhile to determine if the human orthologue can similarly modulate
the activity of client proteins such as ASK1.
In conclusion, we have demonstrated that the rather enigmatic protein TgDJ-1
forms a specific and highly regulated association with CDPK1. We show that TgDJ-1
complexes with CDPK1 and synergizes with calcium in order to potentiate CDPK1
activity. Our data suggest that this association is necessary to maintain normal mi-
croneme secretion and that genetic or chemical manipulations that destabilize or block
the interaction consequently inhibit exocytosis of these important organelles. Further-
more, our findings suggest that intracellular signals (calcium, redox) that regulate
complex stability may function in tandem to further fine-tune this process. Taken
together, our results provide a mechanistic understanding of TgDJ-1 function in
T. gondii microneme exocytosis and identify a previously unknown role for TgDJ-1 as a
kinase-regulatory scaffold. Importantly, these results provide a foundation for studies
that may shed light on how this protein functions in humans, where it plays an
important role in the pathology of diseases such as Parkinson’s disease.
MATERIALS AND METHODS
Parasite strains. The parasite strains used in this study are listed in Table 1.
Compound synthesis. WRR-086 was synthesized as previously described (18).
Parasite and host cell maintenance. Type I T. gondii strain RH was maintained by passage through
confluent monolayers of human foreskin fibroblasts (HFFs). Host cells were cultured as previously
described (35). Parasites were harvested for use in assays by either syringe lysis of infected HFF
monolayers or collection of parasites from culture supernatant after spontaneous lysis of the monolayer.
Parasite transfection and isolation of single-cell clones. Transgenic parasite strains were made by
electroporating the T. gondii strain RHΔku80 (36) with 15 g of linearized plasmid encoding the construct
of interest and selecting for mycophenolic acid (MPA)-xanthine- or 5-fluorodeoxyuridine (FUdR)-resistant
parasites, as described previously (37, 38). Clonal parasites were selected by limiting dilution. Integration
was verified using a locus-specific PCR. Details of all strains used can be found in Table 1.
Transfection constructs. Plasmids for the construction of vectors described were obtained from the
Boothroyd laboratory. These include pTKO2 (used to generate the ΔTgDJ-1 parasite strain), pUPRT (used
to complement ΔTgDJ-1 parasites), and pGRA (used to generate the merodiploid strains). For the
generation of the ΔTgDJ-1 parasite strain, the T1 sequence was amplified using primers 5=-TGTTTCATG
ACGTACCCGACACAGCAC-3= and 5=-GCGACGGGCTGCGGTAGG-3= and the T2 sequence was amplified
using primers 5=-AAGCTTAAGCTTGAGTCGTTACAGCCTAATGAAGCG-3= and 5=-GGGCCCCAAGTCCGAATC
TGCCTAACTCC-3=.
Mutagenesis. In all cases, mutagenesis was performed by site-directed mutagenesis (Stratagene) or
using the Phusion site-directed mutagenesis technique (Thermo).
Cell assays. For all of the cell assays, compound treatments were performed as follows: intracellular
parasites were released from heavily infected host cell monolayers by syringe lysis. Hanks balanced salt
solution (HBSS)-washed parasites were incubated with hydrogen peroxide or compound for 15 min at
TABLE 1 Parasite strain reference table
Strain name
Genetic
background Promoter Expression product
T. gondii ΔTgdj-1 RHΔku80 NAa NA
T. gondii ΔTgdj-1WTcomp RHΔku80ΔTgdj-1 GRA1 FLAG-TgDJ-1WT
T. gondii CDPK1-HA RHΔHXGPRT GRA1 CDPK1-HA
T. gondii TgDJ-1/TgDJ-1C127A RHΔHXGPRT GRA1 FLAG-TgDJ-1C127A
T. gondii TgDJ-1/TgDJ-1C127A/C104A RHΔHXGPRT GRA1 FLAG-TgDJ-1C127A/C104A
T. gondii TgDJ-1/TgDJ-1C127A/R47A RHΔHXGPRT GRA1 FLAG-TgDJ-1C127A/R47A
T. gondii TgDJ-1/TgDJ-1C127A/R27A/R47A RHΔHXGPRT GRA1 FLAG-TgDJ-1C127A/R27A/R47A
aNA, not applicable.
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37°C at the concentration described in the text (unless otherwise stated) before being used for the
appropriate cell assay.
Plaque assays. Toxoplasma plaque formation was assayed as described previously (39).
Microneme secretion assays. Microneme secretion assays quantifying the release of MIC2 into the
extracellular medium were performed as described previously (40), with modifications described previ-
ously (35). For quantification, the following approach was used: mean pixel intensities for GRA7 loading
control bands were measured in ImageJ. Band intensities were initially normalized to the background
intensity measurements of a sample region from the same lane on the blot. GRA7 background subtracted
intensity readings were then compared to the readings from the control lane (e.g., zero time point,
dimethyl sulfoxide [DMSO] treatment). This generated the loading adjustment factor to normalize for
loading against constitutively secreted GRA7. Mean pixel intensities for MIC2 bands were then measured
in ImageJ. Band intensities were initially normalized to the background of a sample region from the same
lane. Background subtracted intensity readings were then multiplied by the adjustment factor deter-
mined above to adjust for loading. Mean values are presented for 3 replicates.
Gliding motility and attachment/invasion assays. 2D motility and the attachment/invasion of host
cells were assayed as described previously (35).
Biochemical fractionation of TgDJ-1. RHΔku80 tachyzoites (50  108) were washed with HBSS,
pelleted, and snap-frozen. The cell pellet was thawed and resuspended in 200 l of hypotonic lysis buffer
(50 mM HEPES, pH 7) and incubated on ice for 30 min. Samples were then spun at 100  g for 1 h. The
supernatant was separated as the “soluble” fraction, and the pellet was resuspended in 200 l of
phosphate-buffered saline (PBS) as the “insoluble” fraction. Fractions were solubilized with equivalent
amounts of reducing Laemmli SDS-PAGE sample buffer, and equivalent volumes were analyzed by
SDS-PAGE and Western blotting.
Immunofluorescence assays. Immunofluorescence assays were performed as described previously
(35) with the antibodies indicated in relevant figure legends.
Preparation of cell extracts. Cell pellets of HBSS-washed extracellular tachyzoites were obtained for
the relevant parasite strains. Pellets were thawed in lysis buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 0.5%
NP-40) and incubated on ice for 30 min. Extracts were clarified by centrifugation at 14,000 rpm and 4°C.
Supernatants were separated and retained as the cell extracts. The protein concentration of extracts was
quantified by bicinchoninic acid (BCA) assay to ensure that equivalent amounts of protein were available
for use in the respective comparative assays.
Immunoprecipitations. Immunoprecipitations (IPs) were performed as follows (unless otherwise
specified in the text). Typically, 200 g cell extract protein was added to 200 l of IP buffer (50 mM Tris
[pH 7.4], 150 mM NaCl, 0.5% NP-40). Anti-HA beads (Pierce) (40 l) were then added to the sample, and
the IPs were performed according to the instructions of the manufacturer. For IPs using conditioned
extracts and recombinant FLAG-tagged TgDJ-1, the samples were adjusted to be reducing and calcium
depleted (2 mM DTT, 5 mM EGTA), oxidizing and calcium depleted (H2O2 [at concentrations specified in
the figure legend or text], 5 mM EGTA), reducing and calcium rich (2 mM DTT, 5 mM CaCl2), or oxidizing
and calcium rich (H2O2 [at concentrations specified in the figure legend or text], 5 mM CaCl2). Once
adjusted, IP samples containing the extracts were incubated for 15 min on ice. FLAG-TgDJ-1 (5 g) was
then added to each, and the samples were incubated for a further 5 min on ice before the addition of
40 l of anti-HA agarose beads (Pierce), with the IP performed according to the instructions of the
manufacturer. Specific extract conditions were maintained for all wash steps unless otherwise stated.
Protein expression and purification. The Toxoplasma gondii DJ-1 gene (TgDJ-1) (18) was PCR
amplified using primers that introduced a 5= NdeI restriction site and a 3= BamHI site. The amplified
insertion was digested with NdeI and BamHI and cloned between these restriction sites in the bacterial
expression vector pET15b (Novagen). The C104S and C127S point mutations were made using standard
site-directed mutagenesis with mutagenic primers. The constructs were transformed into chemically
competent E. coli strain BL21(DE3) (Novagen Merck, Darmstadt, Germany,) for protein expression. The
recombinant protein has a thrombin-cleavable N-terminal hexahistidine tag to facilitate purification
using Ni2 metal affinity chromatography. Protein expression and purification were performed as
described previously (41), except that all buffers contained 2 mM DTT. The absorbance of the purified
sample was measured at 280 nm in DTT-free buffer and converted to a protein concentration using a
calculated extinction coefficient for TgDJ-1 at 280 nm (280) of 7,825 M1 cm1 (Expasy) and a molecular
mass of 29,296 Da. The purified protein was concentrated to 20 mg/ml in storage buffer (25 mM HEPES
[pH 7.5], 100 mM KCl, 2 mM DTT) using a stirred pressure cell concentrator with a 10-kDa molecular mass
cutoff. The purified protein ran as a single band on an overloaded SDS-PAGE gel stained with Biosafe
Coomassie blue (Bio-Rad, Hercules, CA). The concentrated protein was divided into aliquots, rapidly
frozen in liquid nitrogen, and stored at 80°C.
For GST-CDPK1 constructs, CDPK1 was amplified from cDNA and cloned into pGEX-6P1 for expression
with an N-terminal GST tag. Protein was expressed as described above. For preparations of dephospho-
rylated GST-CDPK1, the vector was coexpressed with a construct for the expression of lambda phos-
phatase. Following expression, GST-tagged recombinant proteins were purified using glutathione-
Sepharose beads. Following binding, beads were washed extensively with lysis buffer with 5 mM EGTA
and 2 mM DTT and then stored at 20°C as a 50% slurry in lysis buffer with 5 mM EGTA and 2 mM DTT
and 50% glycerol.
GST pulldown. Glutathione beads (10 l) coated with GST, GST-CDPK1, or GST-CDPK1 coexpressed
with lambda phosphatase were added to 200 l of pulldown buffer (50 mM Tris [pH 7.4], 150 mM NaCl,
5 mM EGTA, 2 mM DTT) and 1 g of recombinant TgDJ-1 (wild-type or mutants as specified in the text
or the figure legends). Samples were incubated with agitation performed at 4°C for 1 h. Beads were then
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washed three times with 500 l of pulldown buffer, and associated proteins were solubilized with equal
volumes of reducing Laemli sample buffer and submitted for analysis by SDS-PAGE, Coomassie staining,
and Western blotting.
Antibodies. Polyclonal murine antibodies were raised against TgDJ-1 as previously described (31).
Polyclonal murine antibodies against CDPK1 were generated in a previous study (31).
Profiling of TgDJ-1 cysteine reactivity. E. coli lysates overexpressing TgDJ-1 were diluted to a 2 mg
protein/ml solution in PBS. Each sample (2 0.5-ml aliquots) was treated with an iodoacetamide probe
at a concentration of either 10 or 100 M using 5 l of a 1 mM or 10 mM stock in DMSO. The labeling
reaction mixtures were incubated at room temperature for 1 h. Click chemistry was performed by the
addition of a 150 M concentration of either a light-tobacco etch virus (TEV) tag (for 10 M iodoacet-
amide [IA] samples) or a heavy TEV tag (for 100 M IA samples) (15 l of a 5 mM stock) as described in
reference 19. Samples were allowed to react at room temperature for 1 h. After the click chemistry step,
the light-tag- and heavy-tag-labeled samples were mixed together and centrifuged (5,900  g, 4 min,
4°C) to pellet the precipitated proteins. The pellets were washed twice in cold MeOH, after which the
pellet was solubilized in PBS containing 1.2% SDS via sonication and heating (5 min and 80°C). Upon
resolubilization, the proteome sample was subjected to streptavidin enrichment and on-bead trypsin and
TEV digestion as previously described (19). The resulting probe-labeled peptides obtained after TEV
digestion were analyzed on a linear trap quadrupole (LTQ)-Orbitrap Discovery mass spectrometer
(Thermo, Fisher) using the Mudpit protocol as previously reported (19). Peptide identification was
achieved using the SEQUEST algorithm and quantified using CIMAGE as reported previously (19).
Spectrophotometric cysteine pKa determination. The pKa value of the reactive cysteine residue
(Cys104) in TgDJ-1 was measured by monitoring the absorption of the thiolate anion at 240 nm as a
function of pH (20, 21). A triple buffer (10 mM boric acid, 10 mM sodium citrate, 10 mM sodium
phosphate) was prepared, and TgDJ-1 protein was added to reach a final concentration of 10 M. The
pH of each sample was changed by the addition of 0.5- to 1.0-l aliquots of 0.5 N or 5.0 N NaOH. After
each addition of NaOH, the absorbance at 240 and 280 nm was measured using a Cary 50 spectropho-
tometer (Varian, Inc., Palo Alto, CA). The A280 value was used to normalize the A240 measurement to the
protein concentration in the cuvette. After spectrophotometric measurement, the pH of each sample was
measured using an Orion micro-pH electrode (Thermo Fisher, Waltham, MA, USA) that had been
calibrated at the beginning of the experiment. Measured absorbance values were converted to an
extinction coefficient at 240 nm (240) using a calculated 280 value for TgDJ-1 of 7,825 M1 cm1
(Expasy). The experiment was performed in triplicate for wild-type protein and once for the C127S and
C104S mutants. The data were fitted to a modified version of the Henderson-Hasselbalch equation (22)
in Prism (GraphPad Software, Inc.). The reported pKa values and associated errors are derived from the
fit procedure.
Protein expression and purification for crystallography. All recombinant protein was expressed
in E. coli Rosetta2(DE3) (EMD Biosciences). N-terminally His6-tagged TgDJ-1 was purified on nickel-
nitrilotriacetic acid (Ni-NTA) resin (Qiagen), and the His6 tag was removed by overnight cleavage using
thrombin (Hematologic Technologies) at 4°C. All proteins were further purified by anion exchange and
gel filtration chromatography. After elution from Ni-NTA, TgDJ-1 was kept in fresh 10 mM DTT for all
subsequent steps.
Crystallization conditions. High-quality crystals of TgDJ-1 grew from a 1:1 mixture of protein
(5 mg/ml)–10 mM HEPES (pH 7.0)–100 mM NaCl–10 mM DTT and 1.5 M ammonium citrate tribasic
(Hampton Research). Crystals were flash frozen in mother liquor for data collection.
Data collection, structure determination, and refinement. The diffraction data were collected at
beamline 11.1 of SSRL (the Stanford Synchrotron Radiation Laboratory) at a wavelength of 0.979 Å and
a temperature of 100 K. Indexing, integration, and scaling of the diffraction data were performed using
the XDS suite (42). Initial phases were obtained by molecular replacement using Phaser (43) and
searching with a homology model of TgDJ-1 created from HsDJ-1 with Modeller (44). Manual rebuilding
in Coot (45) and refinement in refmac (46, 47) led to a final 2.08-Å structure which was deposited in the
Protein Data Bank. The structure showed good stereochemistry (97.5% favored) from Ramachandran
plots as validated by the program MOLPROBITY (48).
Structural figure generation. All structural images were created using PyMOL 1.7.0 (Schrödinger,
LLC).
In vitro kinase assays. Kinase assays were performed using a kinase Glo kit (Promega) and were
optimized according to the instructions of the manufacturer with the following modifications. A standard
assay would include two incubation steps: an initial 30-min incubation at 37°C of a reaction mixture
typically containing recombinant CDPK1 kinase, 50 nM CaCl2, kinase buffer (50 mM Tris [pH 7.4], 10 mM
MgCl2, 2 mM DTT), and TgDJ-1 (unless otherwise stated). Following this initial incubation, 10 M ATP,
10 M syntide, and 500 M CaCl2 were added (unless otherwise stated) and the reaction mixture was
incubated for a further 30 min at 37°C. Assays were then processed according to the instructions of the
manufacturer.
Accession number(s). The 2.08-Å structure determined in this work was deposited in the Protein
Data Bank (PDB accession no. 4XLL).
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